back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-10 12:25 Tx date 2024-08-26 |
$ZYUS
ZYUS Life Sciences Corporation |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+157,894 vol |
186,071 | |
| Filed 2024-09-10 12:16 Tx date 2024-08-26 |
$ZYUS
ZYUS Life Sciences Corporation |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$149,999
+157,894 vol $0.95 each |
452,613 | |
| Filed 2023-06-19 08:23 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
28,177 | ||
| Filed 2023-06-19 08:23 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,618 | ||
| Filed 2023-06-19 08:19 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
294,719 | ||
| Filed 2020-06-12 23:20 Tx date 2020-06-12 |
$ROXG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$64,000
+50,000 vol $1.28 each |
390,000 | |
| Filed 2020-05-25 10:16 Tx date 2020-05-22 |
$ROXG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+97,186 vol |
1,086,279 | |
| Filed 2019-07-26 15:53 Tx date 2019-07-23 |
$ROXG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+110,701 vol |
989,093 | |
| Filed 2018-08-30 Tx date 2018-08-30 |
$ROXG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,000
+25,000 vol $0.92 each |
340,000 | |
| Filed 2018-08-28 Tx date 2018-08-28 |
$ROXG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,500
+25,000 vol $0.94 each |
315,000 | |
| Filed 2018-08-26 Tx date 2018-08-23 |
$ROXG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,500
+25,000 vol $0.94 each |
290,000 | |
| Filed 2018-06-27 Tx date 2018-06-26 |
$ROXG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+103,448 vol |
878,392 | |
| Filed 2018-06-27 Tx date 2018-06-26 |
$ROXG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+120,000 vol |
||
| Filed 2018-06-26 Tx date 2018-06-26 |
$ROXG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+120,000 vol |
894,944 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$CMED
CanniMed Therapeutics Inc. |
Knowles, John Lewis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-1,680,909.12
-39,384 vol $42.68 each |
0 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Knowles, John Lewis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,114
+7,200 vol $1.68 each |
39,384 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Knowles, John Lewis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,114
-7,200 vol $1.68 each |
120,000 | |
| Filed 2017-08-23 Tx date 2017-08-16 |
$ROG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+106,195 vol |
774,944 | |
| Filed 2016-12-24 Tx date 2016-12-24 |
$
CanniMed Therapeutics Inc. |
Knowles, John Lewis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
127,200 | ||
| Filed 2016-12-24 Tx date 2016-12-24 |
$
CanniMed Therapeutics Inc. |
Knowles, John Lewis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
32,184 | ||
| Filed 2016-12-24 Tx date 2016-12-24 |
$
CanniMed Therapeutics Inc. |
Knowles, John Lewis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-24 Tx date 2016-08-22 |
$ROG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+72,727 vol |
668,749 | |
| Filed 2016-07-26 Tx date 2016-07-22 |
$WEL
Wildcat Exploration Ltd. |
Knowles, John Lewis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+200,000 vol |
200,000 | |
| Filed 2016-07-26 Tx date 2016-07-22 |
$WEL
Wildcat Exploration Ltd. |
Knowles, John Lewis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$11,000
+200,000 vol $0.055 each |
371,678 | |
| Filed 2016-04-05 Tx date 2016-02-04 |
$ROG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-36,000
-40,000 vol $0.90 each |
0 | |
| Filed 2015-08-19 Tx date 2015-08-19 |
$ROG
Roxgold Inc. |
Knowles, John Lewis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+166,666 vol |
596,022 |